The effect of human urogastrone on lung phospholipids in fetal rabbits.
Previous in vivo studies have demonstrated that mouse epidermal growth factor (EGF) can enhance fetal lung maturation. We have examined the effect of urogastrone, the human equivalent of mouse EGF and a related growth factor, on the phospholipid profile of fetal rabbit lung lavage and its action on fetal rabbit Type II pneumocytes in culture. Urogastrone (1 or 8 micrograms) given i.p. to fetal rabbits on day 25 of gestation resulted in increased total phospholipid, phosphatidylcholine, phosphatidylinositol and phosphatidylethanolamine contents, increased phosphatidylinositol and phosphatidylethanolamine as a proportion of phospholipid and decreased sphingomyelin as a proportion of phospholipid in lung lavages on day 28. These changes were unaccompanied by alterations in body weight or lung weight, DNA or protein concentrations. Urogastrone (16 micrograms) resulted in increased fetal deaths. Phospholipid profiles on day 27 were unchanged after fetal administration of urogastrone (1 microgram) on day 25. Urogastrone (0.01 and 0.1 ng/ml) added to fetal rabbit Type II pneumocytes in culture for 24 h enhanced the incorporation of radiolabelled choline and thymidine into phosphatidylcholine and DNA respectively. These findings indicate that human urogastrone can alter the phospholipid composition of the rabbit lung in a similar manner to that which occurs during maturation of the lung surfactant system in late pregnancy. This effect can be achieved, at least in part, by a direct action on Type II pneumocytes.
Haigh
R M
RM
Department of Child Health, Manchester University, UK.
Hollingsworth
M
M
Micklewright
L A
LA
Boyd
R D
RD
D'Souza
S W
SW
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005333:Fetus / Q000187:drug effects* / Q000378:metabolism; D008168:Lung / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D010743:Phospholipids / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism*; D011663:Pulmonary Surfactants / Q000096:biosynthesis / Q000378:metabolism; D011817:Rabbits
D010743:Phospholipids; D011663:Pulmonary Surfactants; D004815:Epidermal Growth Factor